Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
about
Viral infection, inflammation and schizophreniaThe environment and susceptibility to schizophrenia.A classification of sociomedical health indicators: perspectives for health administrators and health planners.Animal models of virus-induced neurobehavioral sequelae: recent advances, methodological issues, and future prospects.The brief negative symptom scale: psychometric properties.Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping.Trimethoprim as adjuvant treatment in schizophrenia: a double-blind, randomized, placebo-controlled clinical trial.Are some cases of psychosis caused by microbial agents? A review of the evidence.Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.Results from a hypothesis generating case-control study: herpes family viruses and schizophrenia among military personnelDifferences in glucose tolerance between deficit and nondeficit schizophreniaDeficit schizophrenia: an update.Progress in the study of negative symptoms.Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface.Neuropsychological Profile of Specific Executive Dysfunctions in Patients with Deficit and Non-deficit Schizophrenia.Deficit schizophrenia: Concept and validity.A prenatal interruption of DISC1 function in the brain exhibits a lasting impact on adult behaviors, brain metabolism, and interneuron development.Neurocognitive impairment in the deficit subtype of schizophrenia.
P2860
Q30440507-D64BECD2-9E0F-45C2-844D-8FAEAA774A48Q30459929-FF1C11C3-159B-4B59-A7FE-7ACDD01F01A2Q30478069-8372FE1E-B072-4CD1-B744-BC6CA761E39EQ30481443-8E25B63B-0609-423A-84F4-8F403AAFF2B8Q33608454-113949DB-968B-44A0-9936-E64DF47ED789Q33762494-EFB117D0-F4E8-4571-A390-5949D4B7A479Q33831204-78229B58-B3A6-4F71-829F-609AB6CD04F8Q33950945-EB18A7D0-E68E-4C1C-A259-81157997FE05Q34749296-B16F25DA-39BA-49C3-8F27-AC6B26D30DBAQ35738993-BF7A4DE2-CEB9-4D07-AF8C-CBD1A9A10813Q36031032-591A2516-46EB-4CAC-9645-076D2733B088Q37076493-95414AE5-5E09-42ED-810F-3B91EE6D0374Q37151244-E2A11FB7-7E4F-45EB-BDEE-F74B3E3BC6C0Q37287211-E985342D-C36D-4FAE-A766-CA18251A9028Q37602615-CF6E84E1-43D5-4FE3-8243-7A0FA9DAFCC4Q37936473-6DF34C95-80E7-4810-990B-DDAA2722BD33Q41600823-E956DED3-2FCD-4E6A-9776-C8A41FD95E56Q42028994-E78B7B20-6630-4BB6-BCA9-A2C3673264E1Q45714110-C4D86983-B729-472E-BFCF-AEE46908DB76Q48076142-B97D7B68-62D0-4CCB-8627-381DFCCE9B0B
P2860
Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
@en
Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
@nl
type
label
Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
@en
Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
@nl
prefLabel
Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
@en
Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
@nl
P2093
P2860
P921
P356
P1476
Deficit schizophrenia: association with serum antibodies to cytomegalovirus.
@en
P2093
Andrea Origoni
Cassie Stallings
Faith Dickerson
John Boronow
Robert Yolken
P2860
P304
P356
10.1093/SCHBUL/SBI054
P407
P577
2005-09-15T00:00:00Z